# Gastrointestinal STRING Test With Oral Immunotherapy

> **NCT04943744** · EARLY_PHASE1 · TERMINATED · sponsor: **Stanford University** · enrollment: 13 (actual)

## Conditions studied

- Eosinophilic Disorder
- Food Allergy

## Interventions

- **DEVICE:** Entero-tracker
- **BIOLOGICAL:** omalizumab
- **BIOLOGICAL:** dupliumab

## Key facts

- **NCT ID:** NCT04943744
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-05-17
- **Primary completion:** 2024-05-17
- **Final completion:** 2024-05-17
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Parent study closed to enrollment
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04943744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04943744, "Gastrointestinal STRING Test With Oral Immunotherapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04943744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*